Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Liothyronine | hsa00040 | Pentose and glucuronate interconversions | 9.59E-03 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Liothyronine | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Liothyronine | hsa00561 | Glycerolipid metabolism | 7.94E-03 | 3 | P15121, P14550, Q86XP1 | AKR1B1, AKR1A1, DGKH | More | | Liothyronine | hsa01524 | Platinum drug resistance | 1.79E-02 | 2 | O15392, P11388 | BIRC5, TOP2A | More | | Liothyronine | hsa03010 | Ribosome | 1.60E-02 | 9 | P30050, P40429, P62906, P62917, Q9H0U6, P36578, P05386, P62249, P23396 | RPL12, RPL13A, RPL10A, RPL8, MRPL18, RPL4, RPLP1, RPS16, RPS3 | More | | Liothyronine | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Liothyronine | hsa03030 | DNA replication | 1.48E-02 | 3 | P49005, P33993, P15927 | POLD2, MCM7, RPA2 | More | | Liothyronine | hsa04020 | Calcium signaling pathway | 5.81E-04 | 7 | Q96DU7, Q13557, P21860, P05141, P12236, P26678, P63092 | ITPKC, CAMK2D, ERBB3, SLC25A5, SLC25A6, PLN, GNAS | More | | Liothyronine | hsa04022 | cGMP-PKG signaling pathway | 9.36E-03 | 6 | P61586, P26678, Q99941, P18848, P05141, P12236 | RHOA, PLN, CREBL1, ATF4, SLC25A5, SLC25A6 | More | | Liothyronine | hsa04151 | PI3K-Akt signaling pathway | 1.36E-02 | 9 | P21860, P27348, O14944, P07900, Q15831, P22105, Q99941, P18848, O95988 | ERBB3, YWHAQ, EREG, HSP90AA1, STK11, TNXB, CREBL1, ATF4, TCL1B | More | | Liothyronine | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Liothyronine | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.12E-02 | 5 | P63092, Q99941, P18848, P26678, Q13557 | GNAS, CREBL1, ATF4, PLN, CAMK2D | More | | Liothyronine | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Liothyronine | hsa04659 | Th17 cell differentiation | 3.17E-02 | 3 | P25963, P84022, Q13485 | NFKBIA, SMAD3, SMAD4 | More | | Liothyronine | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Liothyronine | hsa04911 | Insulin secretion | 4.47E-03 | 4 | P63092, Q99941, P18848, Q13557 | GNAS, CREBL1, ATF4, CAMK2D | More | | Liothyronine | hsa04920 | Adipocytokine signaling pathway | 4.31E-02 | 2 | Q9Y478, Q96RR4 | PRKAB1, CAMKK2 | More | | Liothyronine | hsa04925 | Aldosterone synthesis and secretion | 1.68E-02 | 4 | Q99941, P18848, P63092, Q13557 | CREBL1, ATF4, GNAS, CAMK2D | More | | Liothyronine | hsa04927 | Cortisol synthesis and secretion | 2.40E-02 | 3 | Q99941, P18848, P63092 | CREBL1, ATF4, GNAS | More | | Liothyronine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.33E-02 | 4 | P63092, P61586, Q99941, P18848 | GNAS, RHOA, CREBL1, ATF4 | More | | Liothyronine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.25E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Liothyronine | hsa04934 | Cushing syndrome | 1.37E-03 | 5 | Q99941, P18848, P63092, O15169, Q13557 | CREBL1, ATF4, GNAS, AXIN1, CAMK2D | More | | Liothyronine | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | | Liothyronine | hsa05010 | Alzheimer disease | 1.36E-02 | 9 | Q92542, O15239, P05496, P18848, O15169, P05141, P12236, P43686, P62195 | NCSTN, NDUFA1, ATP5G1, ATF4, AXIN1, SLC25A5, SLC25A6, PSMC4, PSMC5 | More | | Liothyronine | hsa05012 | Parkinson disease | 2.88E-03 | 9 | O15239, P05496, P05141, P12236, P63092, P18848, P43686, P62195, Q13557 | NDUFA1, ATP5G1, SLC25A5, SLC25A6, GNAS, ATF4, PSMC4, PSMC5, CAMK2D | More | | Liothyronine | hsa05014 | Amyotrophic lateral sclerosis | 3.92E-02 | 8 | P20333, O15239, P05496, P18848, P43686, P62195, P51991, P35658 | TNFRSF1B, NDUFA1, ATP5G1, ATF4, PSMC4, PSMC5, HNRPA3, NUP214 | More | | Liothyronine | hsa05020 | Prion disease | 1.15E-02 | 9 | P46531, O15239, P05496, P18848, P05141, P12236, P43686, P62195, Q99941 | NOTCH1, NDUFA1, ATP5G1, ATF4, SLC25A5, SLC25A6, PSMC4, PSMC5, CREBL1 | More | | Liothyronine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.57E-02 | 10 | O15239, P05496, P18848, P05141, P12236, P20333, O15169, Q13557, P43686, P62195 | NDUFA1, ATP5G1, ATF4, SLC25A5, SLC25A6, TNFRSF1B, AXIN1, CAMK2D, PSMC4, PSMC5 | More | | Liothyronine | hsa05030 | Cocaine addiction | 2.40E-02 | 3 | P63092, Q99941, P18848 | GNAS, CREBL1, ATF4 | More | | Liothyronine | hsa05031 | Amphetamine addiction | 4.47E-03 | 4 | Q13557, P63092, Q99941, P18848 | CAMK2D, GNAS, CREBL1, ATF4 | More | | Liothyronine | hsa05132 | Salmonella infection | 2.04E-02 | 4 | P25963, Q13489, P10415, Q9BQS8 | NFKBIA, BIRC3, BCL2, FYCO1 | More | | Liothyronine | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Liothyronine | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | | Liothyronine | hsa05203 | Viral carcinogenesis | 7.09E-03 | 6 | Q99941, P18848, P27348, Q15283, P61586, P61978 | CREBL1, ATF4, YWHAQ, RASA2, RHOA, HNRPK | More | | Liothyronine | hsa05206 | MicroRNAs in cancer | 1.54E-02 | 6 | P21860, P61978, P46531, P63279, P22105, P61586 | ERBB3, HNRPK, NOTCH1, UBE2I, TNXB, RHOA | More | | Liothyronine | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Liothyronine | hsa05212 | Pancreatic cancer | 3.52E-02 | 2 | P84022, Q13485 | SMAD3, SMAD4 | More | | Liothyronine | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | | Liothyronine | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Liothyronine | hsa05226 | Gastric cancer | 2.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Liothyronine | hsa05415 | Diabetic cardiomyopathy | 1.92E-02 | 6 | P05141, P12236, O15239, P05496, Q13557, P26678 | SLC25A5, SLC25A6, NDUFA1, ATP5G1, CAMK2D, PLN | More | | |